Infectious Disease

Monday, June 10, 2013: 3:30 PM-4:00 PM

Exhibit Hall A (Pasadena Convention Center)

Board #130
ID: 1718

Influenza Right Size Virologic Surveillance Project: Roadmap Exercise and Evaluation
Stephanie C Chester, Association of Public Health Laboratories
stephanie.chester@aphl.org

Board #139
ID: 1389

Comparison Of Central Line-Associated Bloodstream Infection Demographics, Pennsylvania 2009 – 2011
Lauren Torso, Pennsylvania Department of Health
lauren.torso@gmail.com

Board #140
ID: 1466

Decreasing Clostridium Difficile Infections In The Long-Term Care Population: A Statewide Collaborative Project
Fontaine Sands, Kentucky Department for Public Health
fontaine.sands@ky.gov

Board #141
ID: 1576

Mycobacterium Fortuitum Surgical-Site Infections Associated With An Ambulatory Plastic Surgery Center — Los Angeles County, 2010–2012
Christina Mikosz, Centers for Disease Control and Prevention
dex0@cdc.gov

Board #142
ID: 1676

Review Of Antifungal Treatment Regimens and Clinical Outcomes In An Outbreak Of Fungal Infections Due To Contaminated Methylprednisolone Acetate Injections In Tennessee
Jea-Young Min, Tennessee Department of Health
jea-young.min@tn.gov

Board #143
ID: 1678

Assessment Of Fungal Infection Risk Associated With Specific Contaminated Lots Of Methylprednisolone Acetate, New Jersey 2012
Lisa McHugh, New Jersey Department of Health
lisa.mchugh@doh.state.nj.us

Board #144
ID: 1851

Infection Rejection: Bringing Infection Control Programs to Outpatient Dialysis Centers in New Jersey
Jason Mehr, New Jersey Department of Health and Senior Services
jason.mehr@doh.state.nj.us

Board #145
ID: 1859

Estimating Remaining Risk for use in Targeted Follow-Up in an Outbreak of Fungal Infections Due to Contaminated Methylprednisolone Injections, Tennessee 2012
Meredith L. Kanago, Tennessee Department of Health
meredith.kanago@tn.gov

Board #146
ID: 1877

Exposure “Fingerprinting”: A Tool to Summarize Complex Exposures in the 2012 Fungal Infection Outbreak, Tennessee
Meredith L. Kanago, Tennessee Department of Health
meredith.kanago@tn.gov

Board #147
ID: 1930

Central Line-Associated Bloodstream Infection Data Validation
Joan Baumbach, New Mexico Department of Health
joan.baumbach@state.nm.us

Board #148
ID: 1967

Mandatory Surgical Site Infection Reporting in New Hampshire Ambulatory Surgery Centers
Katrina Hansen, New Hampshire Department of Health and Human Services
katrina.hansen@dhhs.state.nh.us

Board #149
ID: 2055

Impact of Patient Sharing on Interpreting Clostridium Difficile Infection Rates
Valerie B Haley, New York State Department of Health
vbh03@health.state.ny.us

Board #150
ID: 1783

State Public Health Laboratory – NIH-Funded Research Laboratory Collaboration for Carbapenem-Resistant Enterobacteriaceae Surveillance: A Model for Maximizing the Public Health Potential of Taxpayer Money
Marisa A D'Angeli, Washington State Department of Health
marisa.dangeli@DOH.wa.gov

Board #151
ID: 1145

Cluster of Group B Streptococcus in a Neonatal Intensive Care Unit
Ashley Moore, Georgia Department of Public Health
ashley.e.edwards@dhr.state.ga.us

Board #152
ID: 1544

Development Of a Public-Private Sustaining Model For Continuous Hand Hygiene Observations In All Maine Acute Care Hospitals, 2012
Stefanie DeVita, Maine Center for Disease Control and Prevention
stefanie.devita@maine.gov

Board #153
ID: 1275

Viability of Archived Respiratory and Influenza Specimens Used for Laboratory Preparedness Exercise
Allison Seidel, Oak Ridge Institute for Science and Education
allison.seidel.ctr@wpafb.af.mil

Board #154
ID: 1831

Impact of Non-FDA-Approved CLSI Breakpoint Criteria on Laboratory Carbapenem-Resistant Enterobacteriaceae Detection Practices: A State-Wide Assessment
Nicole E. Alexander, Warren Alpert Medical School of Brown University
nalexander2@lifespan.org

See more of: Infectious Diseases
See more of: Poster Sessions

<< Previous Session | Next Session >>